Jane J Lee1, Alison Pedley1, Ellen Marqusee2, Patrice Sutherland1, Udo Hoffmann3, Joseph M Massaro4, Caroline S Fox1,2. 1. National Heart, Lung and Blood Institute's Division of Intramural Research, The Framingham Heart Study, Population Studies Branch, Framingham, Boston, MA, USA. 2. Division of Endocrinology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 3. Department of Radiology, Massachusetts General Hospital, Boston, MA, USA. 4. Department of Biostatistics, Boston University, Boston, MA, USA.
Abstract
OBJECTIVE AND DESIGN: We explored the cross-sectional and longitudinal associations of thyroid function within the normal range with cardiovascular disease (CVD) risk factors and adiposity measures. PATIENTS AND MEASUREMENTS: A total of 3483 (50·4% women) participants for the cross-sectional CVD study and 1630 (41·2% women) participants for the cross-sectional body composition substudy were drawn from the Framingham Third Generation Exam 1; 2912 participants (50·1% women) for the longitudinal CVD study and 713 participants (35·9% women) for the longitudinal body composition substudy were drawn from the Framingham Third Generation Exams 1-2. Thyroid function was assessed by thyrotropin [thyroid-stimulating hormone (TSH)] and free thyroxine (fT4) concentrations within the reference range at Exam 1. The associations between thyroid function and CVD risk factors were modelled via multivariable-adjusted regression models. Multivariable adjustment included age, sex, current smoking, postmenopausal status and BMI. RESULTS: Cross-sectionally, higher TSH concentration was associated with increased odds of hypertriglyceridaemia [odds ratio (OR)=1·10], and higher BMI (β = 0·19 kg/m2 ), total cholesterol (β = 0·05 mmol/l), triglycerides (β = 0·0006 mmol/l) and subcutaneous adipose tissue (SAT) volume (β = 38·8 cm3 ) (all P < 0·05). Cross-sectionally, fT4 was inversely associated with metabolic and adiposity-related CVD risk factors, including obesity (OR = 1·17), hypertriglyceridaemia (OR = 1·09), BMI (β = 0·42 kg/m2 ), total cholesterol (β = 0·05 mmol/l), triglycerides (β = 0·0002 mmol/l), visceral adipose tissue (VAT) volume (β = -20·7 cm3 ) and attenuation (0·17 HU) and VAT/SAT ratio (β = -0·01) (all P < 0·05). However, during 6·1 years of follow-up, baseline TSH and fT4 levels were not longitudinally associated with CVD risk factors and adiposity measures. CONCLUSIONS: Thyroid function within the normal range is cross-sectionally, but not longitudinally, associated with CVD risk factors and adiposity measures.
OBJECTIVE AND DESIGN: We explored the cross-sectional and longitudinal associations of thyroid function within the normal range with cardiovascular disease (CVD) risk factors and adiposity measures. PATIENTS AND MEASUREMENTS: A total of 3483 (50·4% women) participants for the cross-sectional CVD study and 1630 (41·2% women) participants for the cross-sectional body composition substudy were drawn from the Framingham Third Generation Exam 1; 2912 participants (50·1% women) for the longitudinal CVD study and 713 participants (35·9% women) for the longitudinal body composition substudy were drawn from the Framingham Third Generation Exams 1-2. Thyroid function was assessed by thyrotropin [thyroid-stimulating hormone (TSH)] and freethyroxine (fT4) concentrations within the reference range at Exam 1. The associations between thyroid function and CVD risk factors were modelled via multivariable-adjusted regression models. Multivariable adjustment included age, sex, current smoking, postmenopausal status and BMI. RESULTS: Cross-sectionally, higher TSH concentration was associated with increased odds of hypertriglyceridaemia [odds ratio (OR)=1·10], and higher BMI (β = 0·19 kg/m2 ), total cholesterol (β = 0·05 mmol/l), triglycerides (β = 0·0006 mmol/l) and subcutaneous adipose tissue (SAT) volume (β = 38·8 cm3 ) (all P < 0·05). Cross-sectionally, fT4 was inversely associated with metabolic and adiposity-related CVD risk factors, including obesity (OR = 1·17), hypertriglyceridaemia (OR = 1·09), BMI (β = 0·42 kg/m2 ), total cholesterol (β = 0·05 mmol/l), triglycerides (β = 0·0002 mmol/l), visceral adipose tissue (VAT) volume (β = -20·7 cm3 ) and attenuation (0·17 HU) and VAT/SAT ratio (β = -0·01) (all P < 0·05). However, during 6·1 years of follow-up, baseline TSH and fT4 levels were not longitudinally associated with CVD risk factors and adiposity measures. CONCLUSIONS: Thyroid function within the normal range is cross-sectionally, but not longitudinally, associated with CVD risk factors and adiposity measures.
Authors: Annemieke Roos; Stephan J L Bakker; Thera P Links; Rijk O B Gans; Bruce H R Wolffenbuttel Journal: J Clin Endocrinol Metab Date: 2006-11-07 Impact factor: 5.958
Authors: Anders Svare; Tom I L Nilsen; Trine Bjøro; Bjørn O Asvold; Arnulf Langhammer Journal: Clin Endocrinol (Oxf) Date: 2011-06 Impact factor: 3.478
Authors: Caroline S Fox; Michael J Pencina; Ralph B D'Agostino; Joanne M Murabito; Ellen W Seely; Elizabeth N Pearce; Ramachandran S Vasan Journal: Arch Intern Med Date: 2008-03-24
Authors: Greet L Roef; Ernst R Rietzschel; Caroline M Van Daele; Youri E Taes; Marc L De Buyzere; Thierry C Gillebert; Jean-Marc Kaufman Journal: Thyroid Date: 2013-11-14 Impact factor: 6.568
Authors: Tinh-Hai Collet; Jacobijn Gussekloo; Douglas C Bauer; Wendy P J den Elzen; Anne R Cappola; Philippe Balmer; Giorgio Iervasi; Bjørn O Åsvold; José A Sgarbi; Henry Völzke; Bariş Gencer; Rui M B Maciel; Sabrina Molinaro; Alexandra Bremner; Robert N Luben; Patrick Maisonneuve; Jacques Cornuz; Anne B Newman; Kay-Tee Khaw; Rudi G J Westendorp; Jayne A Franklyn; Eric Vittinghoff; John P Walsh; Nicolas Rodondi Journal: Arch Intern Med Date: 2012-05-28
Authors: Nicolien A van Vliet; Evie van der Spoel; Marian Beekman; P Eline Slagboom; Gerard Jan Blauw; Jacobijn Gussekloo; Rudi G J Westendorp; Diana van Heemst Journal: Aging (Albany NY) Date: 2017-10-25 Impact factor: 5.682